What you need to know:
– Leidos hires $ 10 million to a five -year collaboration with the The computer pathology of the University of Pittsburgh and the Center of Excellence of the AI (CPACE) Accelerate the development and use of artificial intelligence (AI) in the detection and management of diseases.
– The partnership aims to create tools fueled by AI for faster detection of diseases, including heart disease and cancer, reduce diagnostic recovery times and allow more efficient management of care.
IA disease detection
Leidos brings his experience to collaboration Frederick National Laboratory for Cancer of the National Cancer Institute of the National Cancer Institute For more than 25 years, as well as its two decades of experience in application of AI to health care and other critical sectors.
Leidos-University of Pittsburgh collaboration focuses on several key objectives:
- Establish a world class research center: The University of Pittsburgh will improve CPACE by further developing its research center for advanced digital pathology. These facilities will support pioneering research in digital pathology and AI diagnosis.
- Development of digital health care solutions: Collaboration will advance technologies fueled by AI, strengthening the leadership of the University of Pittsburgh in digital pathology and allowing Leidos to develop innovative solutions for digital health and diagnosis.
- Acceleration of the global impact: Leidos intends to take advantage of collaboration to deploy digital pathology solutions powered by AI in the public and private health care sectors, which stimulates the marketing of innovative health technologies.
“Our investment aims to use the transformative power of artificial intelligence to accelerate the detection, diagnosis and treatment of diseases that affect millions of people a year,” said Leidos CEO Tom Bell. “These efforts will also focus on the development of future health care specialists and the expansion of care available for poorly served communities, including our veterans.”
